CASI Pharmaceuticals
CASI
#10191
Rank
S$21.78 M
Marketcap
S$1.06
Share price
-3.06%
Change (1 day)
-74.88%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): S-$3.59

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$3.56. In 2024 the company made an earnings per share (EPS) of S-$3.29 a decrease over its 2023 EPS that were of S-$2.60.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.599%
2024S-$3.2926.73%
2023S-$2.60-32.89%
2022S-$3.8711.9%
2021S-$3.46-38.44%
2020S-$5.62-8.96%
2019S-$6.1850%
2018S-$4.1277.78%
2017S-$2.325.88%
2016S-$2.19-22.73%
2015S-$2.83-76.09%
2014S-$11.84318.18%
2013S-$2.83-71.79%
2012S-$10.0465.96%
2011S-$6.05-50%
2010S-$12.10-18.97%
2009S-$14.93-63.64%
2008S-$41.053.57%
2007S-$39.64-60.56%
2006S-$100.5197.22%
2005S-$50.96-2.7%
2004S-$52.38-45.59%
2003S-$96.26-61.8%
2002S-$251.97-25.52%
2001S-$338.32-21.38%
2000S-$430.3413.86%
1999S-$377.96149.53%
1998S-$151.4798.15%
1997S-$76.4410.2%
1996S-$69.36